46
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Trends in Prescription Drug Use among Adults in the United States from 1999–2012

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Importance

          It is important to document patterns of prescription drug use to inform both clinical practice and research.

          Objective

          To evaluate trends in prescription drug use among adults living in the United States.

          Design, Setting, and Participants

          Temporal trends in prescription drug use were evaluated using nationally representative data from the National Health and Nutrition Examination Survey (NHANES). Participants include 37,959 non-institutionalized US adults, aged 20 years and older. Seven NHANES cycles were included (1999–2000 to 2011–2012), and the sample size per cycle ranged from 4,861 to 6,212.

          Exposures

          Calendar year, as represented by continuous NHANES cycle.

          Main Outcome(s) and Measure(s)

          Within each NHANES cycle, use of prescription drugs in the prior 30 days was assessed overall and by drug class. Temporal trends across cycles were evaluated. Analyses were weighted to represent the US adult population.

          Results

          Results indicate an increase in overall use of prescription drugs among US adults between 1999–2000 and 2011–2012 with an estimated 51% of US adults reporting use of any prescription drugs in 1999–2000 and an estimated 59% reporting use in 2011–2012 (Difference: 8%; 95% CI: 3.8%–12%; p-trend<0.001). The prevalence of polypharmacy (use of ≥5 prescription drugs) increased from an estimated 8.2% in 1999–2000 to 15% in 2011–2012 (Difference: 6.6%; 95% CI: 4.4%–8.2%; p-trend<0.001). These trends remained statistically significant with age adjustment. Among the 18 drug classes used by more than 2.5% of the population at any point over the study period, the prevalence of use increased in 11 drug classes including antihyperlipidemic agents, antidepressants, prescription proton-pump inhibitors, and muscle relaxants.

          Conclusions and Relevance

          In this nationally representative survey, significant increases in overall prescription drug use and polypharmacy were observed. These increases persisted after accounting for changes in the age distribution of the population. The prevalence of prescription drug use increased in the majority of, but not all, drug classes.

          Related collections

          Author and article information

          Journal
          7501160
          5346
          JAMA
          JAMA
          JAMA
          0098-7484
          1538-3598
          23 December 2015
          3 November 2015
          03 November 2016
          : 314
          : 17
          : 1818-1831
          Affiliations
          [1 ]Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
          [2 ]Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
          [3 ]Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA
          [4 ]Office of Community & Population Health, Montefiore Medical Center, Bronx, NY, USA
          [5 ]Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Boston, MA, USA
          [6 ]Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
          [7 ]Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA, USA
          [8 ]Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA
          [9 ]Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA
          [10 ]Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
          Author notes
          CORRESPONDING AUTHOR: Elizabeth D. Kantor, PhD MPH, Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, 485 Lexington Avenue, 2 nd Floor, New York, NY, 10017, kantore@ 123456mskcc.org , Phone: 646-888-8247, Fax: 929-321-1516
          [*]

          Denotes shared first authorship

          Article
          PMC4752169 PMC4752169 4752169 nihpa746019
          10.1001/jama.2015.13766
          4752169
          26529160
          fa4bd447-1b9d-40da-b2d0-3be3356b1fe9
          History
          Categories
          Article

          CDC,Trends,Prescription Drugs,NHANES,National Health and Nutrition Examination Survey,Centers for Disease Control and Prevention,Adults

          Comments

          Comment on this article